NO20033699L - Stabil farmasöytisk formulering omfattende torsemidmodifikasjon II - Google Patents
Stabil farmasöytisk formulering omfattende torsemidmodifikasjon IIInfo
- Publication number
- NO20033699L NO20033699L NO20033699A NO20033699A NO20033699L NO 20033699 L NO20033699 L NO 20033699L NO 20033699 A NO20033699 A NO 20033699A NO 20033699 A NO20033699 A NO 20033699A NO 20033699 L NO20033699 L NO 20033699L
- Authority
- NO
- Norway
- Prior art keywords
- torsemide modification
- stable pharmaceutical
- high purity
- pharmaceutical formulation
- modification
- Prior art date
Links
- NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 title abstract 5
- 238000012986 modification Methods 0.000 title abstract 5
- 230000004048 modification Effects 0.000 title abstract 5
- 229960005461 torasemide Drugs 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18328800P | 2000-02-17 | 2000-02-17 | |
| PCT/US2001/005577 WO2002067935A1 (en) | 2000-02-17 | 2001-02-21 | A stable pharmaceutical formulation comprising torsemide modification ii |
| US09/789,424 US6482417B2 (en) | 2000-02-17 | 2001-02-21 | Stable pharmaceutical formulation comprising torsemide modification II |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033699D0 NO20033699D0 (no) | 2003-08-20 |
| NO20033699L true NO20033699L (no) | 2003-10-10 |
Family
ID=27359046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033699A NO20033699L (no) | 2000-02-17 | 2003-08-20 | Stabil farmasöytisk formulering omfattende torsemidmodifikasjon II |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6482417B2 (enExample) |
| EP (1) | EP1292303B1 (enExample) |
| JP (1) | JP2004522780A (enExample) |
| CN (1) | CN1505512A (enExample) |
| AT (1) | ATE266404T1 (enExample) |
| CA (1) | CA2410802A1 (enExample) |
| DE (2) | DE1292303T1 (enExample) |
| DK (1) | DK1292303T3 (enExample) |
| ES (1) | ES2193007T3 (enExample) |
| HR (1) | HRP20030762A2 (enExample) |
| HU (1) | HUP0600143A2 (enExample) |
| IL (1) | IL157539A0 (enExample) |
| IS (1) | IS6919A (enExample) |
| MX (1) | MXPA03007908A (enExample) |
| NO (1) | NO20033699L (enExample) |
| PT (1) | PT1292303E (enExample) |
| SI (1) | SI1292303T1 (enExample) |
| SK (1) | SK11632003A3 (enExample) |
| TR (1) | TR200401462T4 (enExample) |
| WO (1) | WO2002067935A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10013289A1 (de) * | 2000-03-17 | 2001-09-20 | Knoll Ag | Torasemid enthaltende pharmazeutische Zubereitungen |
| US20030022921A1 (en) * | 2001-02-21 | 2003-01-30 | Minutza Leibovici | Stable pharmaceutical formulation comprising torsemide modification II |
| ITMI20020639A1 (it) * | 2002-03-27 | 2003-09-29 | Cosma S P A | Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea |
| WO2005044187A2 (en) * | 2003-10-28 | 2005-05-19 | Glaxo Group Limited | Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| ES2244324B1 (es) * | 2004-03-25 | 2006-11-16 | Ferrer Internacional, S.A. | Composiciones diureticas de liberacion prolongada. |
| CN100421662C (zh) * | 2005-11-08 | 2008-10-01 | 周卓和 | 托拉塞米分散片及其制备方法和应用 |
| CN100372534C (zh) * | 2006-04-20 | 2008-03-05 | 南京海辰药业有限公司 | 托拉塞米冻干制剂及制备方法 |
| US20080213362A1 (en) * | 2007-02-02 | 2008-09-04 | Lawrence Solomon | Compositions and methods using torsemide |
| CN106038500A (zh) * | 2016-05-26 | 2016-10-26 | 南京正科医药股份有限公司 | 一种托拉塞米片 |
| KR20240052937A (ko) * | 2021-07-20 | 2024-04-23 | 미네랄리스 테라퓨틱스, 아이엔씨. | 이치환된 1, 2, 4-트리아진 화합물의 염을 포함하는 가용성 약제학적 조성물 |
| GR1010905B (el) * | 2024-04-15 | 2025-03-10 | Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια, | Δισκιο που περιεχει τορασεμιδη |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1477664A (en) | 1974-04-17 | 1977-06-22 | Christiaens Sa A | Pyridine derivatives |
| DE3529529A1 (de) | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| DE69624559T2 (de) * | 1995-02-28 | 2003-07-10 | Aventis Pharmaceuticals Inc., Bridgewater | Arzneizubereitungen für piperidinalkanolderivate |
| US5914336A (en) * | 1998-06-02 | 1999-06-22 | Boehringer Mannheim Gmbh | Method of controlling the serum solubility of orally administered torasemide and composition relating thereto |
| KR20020025217A (ko) * | 1999-08-11 | 2002-04-03 | 추후보정 | 토르세미드 동질이상 |
-
2001
- 2001-02-21 ES ES01911078T patent/ES2193007T3/es not_active Expired - Lifetime
- 2001-02-21 AT AT01911078T patent/ATE266404T1/de not_active IP Right Cessation
- 2001-02-21 SK SK1163-2003A patent/SK11632003A3/sk not_active Application Discontinuation
- 2001-02-21 CN CNA018231683A patent/CN1505512A/zh active Pending
- 2001-02-21 TR TR2004/01462T patent/TR200401462T4/xx unknown
- 2001-02-21 DE DE1292303T patent/DE1292303T1/de active Pending
- 2001-02-21 MX MXPA03007908A patent/MXPA03007908A/es not_active Application Discontinuation
- 2001-02-21 WO PCT/US2001/005577 patent/WO2002067935A1/en not_active Ceased
- 2001-02-21 HR HR20030762A patent/HRP20030762A2/xx not_active Application Discontinuation
- 2001-02-21 JP JP2002567302A patent/JP2004522780A/ja not_active Withdrawn
- 2001-02-21 HU HU0600143A patent/HUP0600143A2/hu unknown
- 2001-02-21 EP EP01911078A patent/EP1292303B1/en not_active Revoked
- 2001-02-21 SI SI200130132T patent/SI1292303T1/xx unknown
- 2001-02-21 DE DE60103276T patent/DE60103276T2/de not_active Expired - Fee Related
- 2001-02-21 DK DK01911078T patent/DK1292303T3/da active
- 2001-02-21 US US09/789,424 patent/US6482417B2/en not_active Expired - Fee Related
- 2001-02-21 CA CA002410802A patent/CA2410802A1/en not_active Abandoned
- 2001-02-21 IL IL15753901A patent/IL157539A0/xx unknown
- 2001-02-21 PT PT01911078T patent/PT1292303E/pt unknown
-
2003
- 2003-08-20 IS IS6919A patent/IS6919A/is unknown
- 2003-08-20 NO NO20033699A patent/NO20033699L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03007908A (es) | 2004-12-06 |
| SK11632003A3 (sk) | 2004-04-06 |
| DE1292303T1 (de) | 2003-09-18 |
| JP2004522780A (ja) | 2004-07-29 |
| NO20033699D0 (no) | 2003-08-20 |
| PT1292303E (pt) | 2004-09-30 |
| IS6919A (is) | 2003-08-20 |
| IL157539A0 (en) | 2004-03-28 |
| ES2193007T1 (es) | 2003-11-01 |
| CA2410802A1 (en) | 2002-09-06 |
| HRP20030762A2 (en) | 2005-08-31 |
| WO2002067935A1 (en) | 2002-09-06 |
| SI1292303T1 (en) | 2004-10-31 |
| HUP0600143A2 (en) | 2006-10-28 |
| ATE266404T1 (de) | 2004-05-15 |
| US20020035135A1 (en) | 2002-03-21 |
| EP1292303A1 (en) | 2003-03-19 |
| DE60103276T2 (de) | 2005-06-23 |
| EP1292303A4 (en) | 2003-07-09 |
| DK1292303T3 (da) | 2004-09-06 |
| DE60103276D1 (de) | 2004-06-17 |
| US6482417B2 (en) | 2002-11-19 |
| CN1505512A (zh) | 2004-06-16 |
| ES2193007T3 (es) | 2004-11-01 |
| EP1292303B1 (en) | 2004-05-12 |
| TR200401462T4 (tr) | 2004-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| UA84266C2 (uk) | Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування | |
| HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
| EE200300033A (et) | Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
| HUP0101237A1 (hu) | Elnyújtott kioldódású gyógyszerkészítmények | |
| YU57600A (sh) | Derivarti biciklične hidroksaminske kiseline | |
| DE60120648D1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
| TW200510375A (en) | New compounds | |
| IL153297A0 (en) | Compounds and compositions for delivering active agents | |
| NO20003196D0 (no) | Umiddelbart smeltende doseringsformulering | |
| SE9504661D0 (sv) | New compounds | |
| AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
| AU3850600A (en) | Dalda analogs and their use | |
| MY127350A (en) | Flash-melt oral dose formulations | |
| DK1292303T3 (da) | Stabil farmaceutisk formulering omfattende torsemidmodifikation II | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| DK1007006T3 (da) | Formulering af cefadroxilmonohydrattablet | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| SE0102440D0 (sv) | New compound | |
| TR200200473T2 (tr) | Rar selektif retinoid agonistleri. | |
| SE0001916D0 (sv) | Novel formulation | |
| SE9803107D0 (sv) | Novel Compunds | |
| YU24603A (sh) | Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin | |
| MD20040296A (ro) | Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |